Very long-term outcome of acute promyelocytic leukemia after treatment with all-trans retinoic acid and chemotherapy: the European APL Group experienceLionel Adès, Claude Gardin, Nathalie Fegeux et al.|Blood|2009Cited by 251
Is Cytarabine Useful in the Treatment of Acute Promyelocytic Leukemia? Results of a Randomized Trial From the European Acute Promyelocytic Leukemia GroupLionel Adès, Pierre Fenaux, Sylvie Chevret et al.|Journal of Clinical Oncology|2006Cited by 166
Treatment of newly diagnosed acute promyelocytic leukemia (APL): a comparison of French-Belgian-Swiss and PETHEMA resultsLionel Adès, Pierre Fenaux, Miguel Á. Sanz et al.|Blood|2007Cited by 157
Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 93 trialStéphane de Botton, for the European Apl Group, Sylvie Chevret et al.|British Journal of Haematology|2000Cited by 145
Improved Outcome of Acute Promyelocytic Leukemia With High WBC Counts Over the Last 15 Years: The European APL Group ExperienceCharikleia Kelaïdi, Lionel Adès, Sylvie Chevret et al.|Journal of Clinical Oncology|2009Cited by 120